Anand Mehra
Director, Aerie Pharmaceuticals.
Companies
- Merus N.V.Board member Jan 2, 2020 to now1
- Aclaris Therapeutics, Inc.Board member Oct 6, 2015 to now2
- Marinus Pharmaceuticals (United States)Board member Jul 31, 2014 to Aug 5, 20163
- Aerie PharmaceuticalsBoard member Oct 25, 2013 to Apr 16, 20154
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Aclaris Therapeutics, Inc. ACRS726,403 shares5$2.5M at $3.38Jun 5, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 5, 2026Exercised options 11,580 shares of Aclaris Therapeutics, Inc.5
- Jun 6, 2025Exercised options 4,793 shares of Aclaris Therapeutics, Inc.6
- Nov 19, 2024Bought 666,666 shares at $2.25 of Aclaris Therapeutics, Inc.7
- Jun 1, 2024Exercised options 4,660 shares of Aclaris Therapeutics, Inc.8
- Jun 2, 2023Exercised options 4,507 shares of Aclaris Therapeutics, Inc.9
- Jun 3, 2022Exercised options 3,356 shares of Aclaris Therapeutics, Inc.10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARMerus N.V., Board member
- 2
- 3
- 4SEC EDGARAerie Pharmaceuticals, Board member
- 5
- 6SEC EDGARForm 4 filed Jun 9, 2025
- 7SEC EDGARForm 4 filed Nov 20, 2024
- 8SEC EDGARForm 4 filed Jun 4, 2024
- 9SEC EDGARForm 4 filed Jun 5, 2023
- 10SEC EDGARForm 4 filed Jun 6, 2022